Joseph Kim
@JMKimMD
Followers
257
Following
772
Media
7
Statuses
96
Cardiology Fellow @BIDMCCVI and @SmithBIDMC by way of @BrighamMedRes
Joined June 2022
Congrats @katerinadangas on leading this important study evaluating limb outcomes between Medicare FFS and Medicare Advantage patients! @SmithBIDMC @BidmcCvi @rwyeh @rkwadhera @JMKimMD @AndrewOseran
Outcomes of Endovascular Revascularization for Chronic Limb-Threatening Ischemia in Medicare Advantage and Medicare Fee-For-Service Beneficiaries @rwyeh @rkwadhera @JMKimMD @EricSecemskyMD #AHAJournals
https://t.co/EwfZEURf6o
2
4
33
Outcomes of Endovascular Revascularization for Chronic Limb-Threatening Ischemia in Medicare Advantage and Medicare Fee-For-Service Beneficiaries @rwyeh @rkwadhera @JMKimMD @EricSecemskyMD #AHAJournals
https://t.co/EwfZEURf6o
0
3
11
Racial disparities persist in the use of adjunctive PCI technologyđź«€ Mentored by the exceptional @EricSecemskyMD, guided by the wonderful @rwyeh, and with unwavering support from @JMKimMD. Proud to present one of my @SarnoffCardio supported projects. https://t.co/MTZ4t5Nnxo
ahajournals.org
BACKGROUND: Racial differences in the use and outcomes of intravascular imaging (IVI) and invasive physiology (IP) during percutaneous coronary intervention (PCI) are underreported in the United...
1
8
17
Study Analyzes Outcome Disparities for Black Patients With CLTI | #SCAI2025
https://t.co/rw2TBokEBv
evtoday.com
May 7, 2025—The Society for Cardiovascular Angiography & Interventions (SCAI) recently announced the presentation of findings showing that B
0
5
10
Thank you @MyJSCAI for the opportunity to discuss our review on the evolving role of transcatheter aspiration for endocarditis, an exciting area with significant clinical and research potential.
📺Percutaneous Mechanical Aspiration is emerging as a complementary approach for carefully selected #IE pts. In this review, experts discuss PMA's evolving role in global IE mgmt. 🔍Watch the highlights: https://t.co/XXfVaQcMdv 📚Read the full article: https://t.co/XwDoyBVYnE
1
7
16
Just spotted: four T32 fellows learning about poisson regression for their @HarvardChanSPH Masters!
1
3
28
A privilege to represent @SmithBIDMC in presenting our work on the final analysis of SAFE-PAD at #ACC25! A monumental effort by @EricSecemskyMD, @rwyeh and team to show the safety of peripheral drug-coated devices. Great company, great food, great times!
0
6
24
A privilege to cover a critical and impactful study by the great @BradleyPetek!
Survival After Sudden Cardiac Arrest Improves in Young Athletes, but Racial Disparities Persist Written by @JMKimMD! Summary, analysis and more #ACC25 coverage below! https://t.co/4TGTIhNPbb
@CMichaelGibson @ceciliabahit
0
0
5
Congrats to Sarnoff Fellow @frank_medina_ on his induction to the Gold Humanism Honor Society, recognizing medical students and physicians for their compassionate care! @SarnoffCardio @UChicagoMed
1
3
20
Thank you🙏to @JACCJournals for highlighting our work on the effect of contemporary events on femoropopliteal revascularizations among Medicare beneficiaries! Only possible thanks to the leadership of @EricSecemskyMD, @rwyeh and others @SmithBIDMC!
Fem-pop revascularizations: Undergoing a substantial decline? See the trends: https://t.co/m1TKc3GSG8
#JACC #Revascularization #Revasc @rwyeh @JMKimMD
1
4
14
Study finds adverse outcomes after decreased use of #paclitaxel-coated devices @EricSecemskyMD
cardiovascularnews.com
A recent analysis of over 270,000 Medicare fee-for-service beneficiaries has found an increase in adverse outcomes and death after a US FDA warning led to decreased use of paclitaxel-coated devices...
0
2
7
To kick off the new year, @EricSecemskyMD and I discuss the APEX-AV trial and the newly approved AlphaVac device for PE mechanical thrombectomy in @MyJSCAI. 2025 will be a great year for PE therapies, with lots of trials in the pipeline! https://t.co/3mB0aJW30G
2
4
19
Momentary concerns over paclitaxel-coated devices may have put PAD patients at risk @SCAI @JACCjournals @ACCinTouch @ACCmediacenter
cardiovascularbusiness.com
Back in 2019, the FDA issued a warning about the use of paclitaxel-coated devices when treating peripheral artery disease. The agency took back that warning in 2023, but it appears to have made a...
0
2
4
jacc.org
0
0
2
Excited to share our study of changing practice patterns in the use of drug-coated devices in fem-pop revascularizations, now in @JACCJournals! Grateful always to @EricSecemskyMD for his mentorship, and to @SCAI for the Early Career Research Grant supporting our work!
Trends in fem-pop revascularization respond to pivotal events; Late 2010s paclitaxel safety concerns were associated with ⬇ drug-coated device use and ⬆ mortality, exacerbated by COVID-19. @JMKimMD @EricSecemskyMD et al in @JACCJournals: https://t.co/xd6Wl6SvYG
3
4
22
Amazing work by @lucas_marinacci to highlight the challenges and need for more evidence for percutaneous options of source control in infective endocarditis. Exciting times ahead! @BIDMCVFellows @SmithBIDMC
Percutaneous mechanical aspiration for endocarditis may help achieve source control and reduce embolization risk -- but better evidence is needed. In this article we go through each IE subtype, discuss the available evidence, and outline the field's future https://t.co/iRCAZ1liRV
0
0
8
Huge congratulations to our incoming F1 class!!
We are so thrilled to welcome this truly exceptional group of cardiology fellows to Beth Israel Deaconess Medical Center!!!
0
0
37